Plain-English translation of NCT06973902 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing a medical device called cardiac contractility modulation (CCM) for people with advanced heart failure. Before receiving the device, you'll undergo a special heart ultrasound test using a medication called dobutamine to see how your heart responds to stress. The study will track whether this test can predict which patients will benefit most from the CCM device implant.
Heart failure is a serious condition that limits what patients can do and requires frequent hospital visits. While medications help many people, some patients need additional treatment options. This trial is looking for a way to identify which patients are most likely to benefit from this treatment before the expensive device is implanted.
You likely qualify if…
You likely don't qualify if…
You would first undergo a dobutamine stress echocardiogram — a special ultrasound of your heart performed while a medication is given to make your heart work harder, so doctors can see how it responds. Based on your test results, you'll be placed into one of two groups to track how well the cardiac contractility modulation device works for you. You'll then receive the implant and be followed over time to measure improvements in your heart function, symptoms, and quality of life.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Italy